Could your own bone marrow cells help fight Parkinson's?

NCT ID NCT07751640

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This early-stage trial is testing whether a single same-day treatment using a patient's own bone marrow cells is safe and tolerable for people with Parkinson's disease or related conditions. The procedure involves drawing bone marrow from the hip, giving one portion through an IV, and delivering a concentrated portion as a nasal spray. The study also looks at whether the treatment might affect biological age markers in the blood, offering a hint of potential long-term effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A single same-day treatment using the patient's own bone marrow: one part given intravenously and one part concentrated and given as a nasal spray.
What this could lead to
If safe and promising, this approach could point toward a new way to ease Parkinson's symptoms or slow the disease by using a patient's own cells.
What could go wrong
This is a very early, small pilot study (10 people) focused mainly on safety, not proof of benefit. The treatment may not improve symptoms, and any procedure carries risks like infection or discomfort from the bone marrow draw.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATYPICAL PARKINSONISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Boulder Biologics Research Center

    Boulder, Colorado, 80303, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.